ID
41354
Descripción
Study ID: 105043/013 Clinical Study ID: 105043/013 Study Title: An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (Protocol SKF105043/013) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00039858 Sponsor: GlaxoSmithKline Collaborators: Encysive Pharmaceuticals Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Argatroban Trade Name: N/A Study Indication: Thrombosis This Study evaluates the safety and the efficacy of i.v. Argatroban treatment in paediatric patients which require anticoagulants but aren't suitable for Heparin treatment. The study consists of screening visit (pre-treatment examination), treatment period of maximum 14 days after reaching therapeutical dose, post-treatment visit (once the treatment is stopped or after 14 days) and a follow-up visit which follows 30 days (+/- 14 days) after clinical resolution of underlying condition or after the end of the 14-day study period. Treatment can be continued after the 14-day study period if needed but such treatment isn't part of this Study. See https://clinicaltrials.gov/ct2/show/NCT00039858 This Form has to be filled in during the Treatment period after Circuit Prime is administered and whenever a Bolus of Argatroban is administered. Continuous infusions are recorded in a separate form.
Link
https://clinicaltrials.gov/ct2/show/NCT00039858
Palabras clave
Versiones (1)
- 3/9/20 3/9/20 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
3 de septiembre de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858
Dosing Information - Circuit Prime and Bolus
- StudyEvent: ODM
Descripción
Dosing Information - Circuit Prime
Alias
- UMLS CUI-1
- C0678766
- UMLS CUI-2
- C1533716
- UMLS CUI-3
- C3805286
Descripción
*Protocol violation
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3805286
Descripción
Part to be filled in: μg **Recommend 50μg/750mL
Tipo de datos
integer
Unidades de medida
- μg
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C3805286
Descripción
Part to be filled in: mL **Recommend 50μg/750mL
Tipo de datos
integer
Unidades de medida
- mL
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C3805286
Descripción
Dosing Information - Bolus
Alias
- UMLS CUI-1
- C0678766
- UMLS CUI-2
- C1533716
- UMLS CUI-3
- C1511237
Descripción
Number of bolus administered
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1511237
- UMLS CUI [1,2]
- C2348184
Descripción
Please fill in for all nine bolus numbers.
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1511237
- UMLS CUI [1,2]
- C1521801
Descripción
Bolus dose
Tipo de datos
integer
Unidades de medida
- mcg/kg
Alias
- UMLS CUI [1]
- C1511237
Descripción
(dd-mmm-yyyy)
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C1511237
- UMLS CUI [1,2]
- C0808070
Descripción
(0000-2359)
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C1511237
- UMLS CUI [1,2]
- C1301880
Descripción
(0000-2359)
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C1511237
- UMLS CUI [1,2]
- C1522314
Similar models
Dosing Information - Circuit Prime and Bolus
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C2348184 (UMLS CUI [1,2])
C1533716 (UMLS CUI-2)
C3805286 (UMLS CUI-3)
C0304229 (UMLS CUI [1,2])
C3805286 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C3805286 (UMLS CUI [1,3])
C1533716 (UMLS CUI-2)
C1511237 (UMLS CUI-3)
C2348184 (UMLS CUI [1,2])
C1521801 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,2])
Sin comentarios